{"meta":{"id":"https:\/\/api.iclient.ifeng.com\/ipadtestdoc?aid=ucms_80A6zdNQxPt","type":"doc","o":"1","documentId":"ucms_80A6zdNQxPt"},"body":{"newStatus":"1","documentId":"ucms_80A6zdNQxPt","staticId":"ucms_80A6zdNQxPt","title":"未名医药:股东高宝林拟减持总股本的6%","shareTitle":"未名医药:股东高宝林拟减持总股本的6%","thumbnail_doc":"","thumbnail":"","source":"财联社-滚动新闻","author":"财联社-滚动新闻","editorcode":"欧抓","editTime":"2020-09-29 16:02:51","updateTime":"2020\/09\/29 16:02:51","wapurl":"http:\/\/\/\/finance.ifeng.com\/c\/80A6zdNQxPt","introduction":"","wwwurl":"http:\/\/\/\/finance.ifeng.com\/c\/80A6zdNQxPt","commentsUrl":"ucms_80A6zdNQxPt","commentCount":0,"text":"
财联社9月29日讯,未名医药公告,公司持股16.51%股东高宝林计划将于本公告披露之日起15个交易日后的六个月内通过集中竞价方式、大宗交易方式或两种方式相结合减持本公司股份,减持数量合计不超过3958万股,即减持比例不超过公司总股本的6%。<\/p>","img":[],"summary":"财联社9月29日讯,未名医药公告,公司持股16.51%股东高宝林计划将于本公告披露之日起15个交易日后的六个月内通过集中竞价方式、大宗交易方式或两种方式相结合减","sharesummary":"财联社9月29日讯,未名医药公告,公司持股16.51%股东高宝林计划将于本公告披露之日起15个交易日后的六个月内通过集中竞价方式、大宗交易方式或两种方式相结合减","commentType":"0","showclient":"0","shareurl":"https:\/\/ishare.ifeng.com\/c\/s\/v002-_eWV8EtdVaEH5bJw47tJut6IeNgYqdNkfcnnXz0DBqI__","praise":"0","like_num":"0"}}